Antigen-specific human antibodies from mice comprising four distinct genetic modifications
- 1 April 1994
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 368 (6474), 856-859
- https://doi.org/10.1038/368856a0
Abstract
Human sequence monoclonal antibodies, which in theory combine high specificity with low immunogenicity, represent a class of potential therapeutic agents. But nearly 20 years after Köhler and Milstein first developed methods for obtaining mouse antibodies, no comparable technology exists for reliably obtaining high-affinity human antibodies directed against selected targets. Thus, rodent antibodies, and in vitro modified derivatives of rodent antibodies, are still being used and tested in the clinic. The rodent system has certain clear advantages; mice are easy to immunize, are not tolerant to most human antigens, and their B cells form stable hybridoma cell lines. To exploit these advantages, we have developed transgenic mice that express human IgM, IgG and Ig kappa in the absence of mouse IgM or Ig kappa. We report here that these mice contain human sequence transgenes that undergo V(D)J joining, heavy-chain class switching, and somatic mutation to generate a repertoire of human sequence immunoglobulins. They are also homozygous for targeted mutations that disrupt V(D)J rearrangement at the endogenous heavy- and kappa light-chain loci. We have immunized the mice with human proteins and isolated hybridomas secreting human IgG kappa antigen-specific antibodies.Keywords
This publication has 19 references indexed in Scilit:
- Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgMInternational Immunology, 1994
- Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locusInternational Immunology, 1993
- Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibodyClinical Immunology and Immunopathology, 1992
- Immune Receptors: Targets for Therapy of Leukemia/Lymphoma, Autoimmune Diseases and for the Prevention of Allograft RejectionAnnual Review of Immunology, 1992
- Humanized antibodies for therapyNature, 1991
- Man-made antibodiesNature, 1991
- A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locusNature, 1990
- Immunoglobulin‐bearing B cells reconstitute and maintain the murine Ly‐1 B cell lineageEuropean Journal of Immunology, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975